Paracetamol IV Market Size

Paracetamol IV Market Size

The global paracetamol IV market size was valued at USD 860.7 million in 2024 and is estimated to grow at a CAGR of 4.2% from 2025 to 2034. Paracetamol IV is widely used for its effective analgesic and antipyretic properties, offering rapid relief in cases where oral administration is not feasible, such as post-surgical recovery, severe infections, or in patients with compromised gastrointestinal function.

To get key market trends

  Download Free Sample

The rising prevalence of acute pain and fever management in hospital settings, particularly post-operative and trauma care, has significantly increased the demand for fast-acting analgesics, thereby boosting the intravenous paracetamol market. Additionally, the market is bolstered by growing awareness and adoption of non-opioid pain treatment due to the risks associated with opioid use, including addiction and side effects.
 

For instance, studies have reported that intravenous paracetamol reduced postoperative opioid consumption and decreased postoperative pain scores without increasing adverse effects. Thus, paracetamol IV provides a safer alternative with minimal adverse reactions, aligning with the increasing emphasis on enhanced recovery after surgery (ERAS) protocols. Moreover, its favorable safety profile compared to opioids, with a reduced risk of dependency and fewer adverse effects, has further fueled its market penetration.
 

Paracetamol IV (intravenous) is a formulation of paracetamol (acetaminophen) designed for intravenous administration. It is commonly used in hospitals and clinical settings to manage moderate to severe pain and fever when oral or rectal administration is not feasible.